212 related articles for article (PubMed ID: 29804367)
1. [Research advances in hepatocyte-like cells from human induced pluripotent stem cells and their application].
Cao YY; Zeng X
Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):69-72. PubMed ID: 29804367
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells.
Wang J; Zhao P; Wan Z; Jin X; Cheng Y; Yan T; Qing S; Ding N; Xin S
Cell Biochem Funct; 2016 Oct; 34(7):475-482. PubMed ID: 27569862
[TBL] [Abstract][Full Text] [Related]
3. Analysis of differentially expressed genes among human hair follicle-derived iPSCs, induced hepatocyte-like cells, and primary hepatocytes.
Xu Z; He X; Shi X; Xia Y; Liu X; Wu H; Li P; Zhang H; Yin W; Du X; Li L; Li Y
Stem Cell Res Ther; 2018 Aug; 9(1):211. PubMed ID: 30092828
[TBL] [Abstract][Full Text] [Related]
4. Agonist c-Met Monoclonal Antibody Augments the Proliferation of hiPSC-derived Hepatocyte-Like Cells and Improves Cell Transplantation Therapy for Liver Failure in Mice.
Yuan L; Zhang Y; Liu X; Chen Y; Zhang L; Cao J; Li X; Wang M; Wu K; Zhang J; Liu G; Tang Q; Yuan Q; Cheng T; Xia N
Theranostics; 2019; 9(7):2115-2128. PubMed ID: 31037160
[No Abstract] [Full Text] [Related]
5. Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation.
Jozefczuk J; Prigione A; Chavez L; Adjaye J
Stem Cells Dev; 2011 Jul; 20(7):1259-75. PubMed ID: 21162674
[TBL] [Abstract][Full Text] [Related]
6. [Generation of Zone-specific Hepatocyte-like Cells from Human Induced Pluripotent Stem Cells for Accurate Prediction of Drug-induced Hepatotoxicity].
Mitani S
Yakugaku Zasshi; 2019; 139(12):1509-1512. PubMed ID: 31787637
[TBL] [Abstract][Full Text] [Related]
7. Donor-Dependent and Other Nondefined Factors Have Greater Influence on the Hepatic Phenotype Than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte-Like Cells.
Heslop JA; Kia R; Pridgeon CS; Sison-Young RL; Liloglou T; Elmasry M; Fenwick SW; Mills JS; Kitteringham NR; Goldring CE; Park BK
Stem Cells Transl Med; 2017 May; 6(5):1321-1331. PubMed ID: 28456008
[TBL] [Abstract][Full Text] [Related]
8. Differentiation and transplantation of human induced pluripotent stem cell-derived hepatocyte-like cells.
Asgari S; Moslem M; Bagheri-Lankarani K; Pournasr B; Miryounesi M; Baharvand H
Stem Cell Rev Rep; 2013 Aug; 9(4):493-504. PubMed ID: 22076752
[TBL] [Abstract][Full Text] [Related]
9. Pluripotent Stem Cell-Derived Hepatocyte-like Cells: Induction Methods and Applications.
Luo Q; Wang N; Que H; Mai E; Hu Y; Tan R; Gu J; Gong P
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511351
[TBL] [Abstract][Full Text] [Related]
10. hiPSC-derived hepatocytes closely mimic the lipid profile of primary hepatocytes: A future personalised cell model for studying the lipid metabolism of the liver.
Kiamehr M; Alexanova A; Viiri LE; Heiskanen L; Vihervaara T; Kauhanen D; Ekroos K; Laaksonen R; Käkelä R; Aalto-Setälä K
J Cell Physiol; 2019 Apr; 234(4):3744-3761. PubMed ID: 30146765
[TBL] [Abstract][Full Text] [Related]
11. Liver biopsy derived induced pluripotent stem cells provide unlimited supply for the generation of hepatocyte-like cells.
Calabrese D; Roma G; Bergling S; Carbone W; Mele V; Nuciforo S; Fofana I; Campana B; Szkolnicka D; Hay DC; Tchorz J; Bouwmeester T; Wieland S; Heim MH
PLoS One; 2019; 14(8):e0221762. PubMed ID: 31465481
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte-like cells derived from human induced pluripotent stem cells using small molecules: implications of a transcriptomic study.
Gao X; Li R; Cahan P; Zhao Y; Yourick JJ; Sprando RL
Stem Cell Res Ther; 2020 Sep; 11(1):393. PubMed ID: 32917265
[TBL] [Abstract][Full Text] [Related]
13. Toxicological applications of human induced pluripotent stem cell-derived hepatocyte-like cells: an updated review.
Gao X; Yourick JJ; Sprando RL
J Toxicol Sci; 2023; 48(8):441-456. PubMed ID: 37532578
[TBL] [Abstract][Full Text] [Related]
14. Advances in Human Induced Pluripotent Stem Cell-Derived Hepatocytes for Use in Toxicity Testing.
Wills LR; Rajagopalan P
Ann Biomed Eng; 2020 Mar; 48(3):1045-1057. PubMed ID: 31372857
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of induced pluripotent stem cells to hepatocyte-like cells on cellulose nanofibril substrate.
Poorna MR; Sudhindran S; Thampi MV; Mony U
Colloids Surf B Biointerfaces; 2021 Feb; 198():111466. PubMed ID: 33243549
[TBL] [Abstract][Full Text] [Related]
16. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host.
Sa-Ngiamsuntorn K; Wongkajornsilp A; Phanthong P; Borwornpinyo S; Kitiyanant N; Chantratita W; Hongeng S
Virol J; 2016 Apr; 13():59. PubMed ID: 27044429
[TBL] [Abstract][Full Text] [Related]
17. Stem-cell derived hepatocyte-like cells for the assessment of drug-induced liver injury.
Donato MT; Tolosa L
Differentiation; 2019; 106():15-22. PubMed ID: 30844688
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of Toxic Advanced Glycation End-Products Induces Cytotoxicity and Inflammation in Hepatocyte-Like Cells Differentiated from Human Induced Pluripotent Stem Cells.
Kikuchi C; Sakasai-Sakai A; Okimura R; Tanaka H; Takata T; Takeuchi M; Matsunaga T
Biol Pharm Bull; 2021; 44(10):1399-1402. PubMed ID: 34602548
[TBL] [Abstract][Full Text] [Related]
19. Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity.
Choudhury Y; Toh YC; Xing J; Qu Y; Poh J; Li H; Tan HS; Kanesvaran R; Yu H; Tan MH
Sci Rep; 2017 Jan; 7():41238. PubMed ID: 28120901
[TBL] [Abstract][Full Text] [Related]
20. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.
Gómez-Lechón MJ; Tolosa L
Arch Toxicol; 2016 Sep; 90(9):2049-2061. PubMed ID: 27325232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
